Zhou et al. presented a poster at the 2018 ISSX Conference in Montreal on “Elimination of [14C]-LY3023414 by Aldehyde Oxidase...
View Article
Hypha Discovery have issued a policy detailing our position on data protection in relation to the GDPR regulations that came...
View Article
Liam is attending the Drug Discovery Chemistry Lead Optimization for Drug Metabolism and Safety meeting on April 6th 2018 in...
View Article
Single-step microbial production of sequential hydroxylated glucuronidated metabolites is the topic of our first scientific newsletter for 2018. Many drugs...
View Article
Hypha’s newsletter for Q4 2017 focusses on the selective production of N-oxide metabolites, especially relevant where there is potential for...
View Article
This quarter we look at interesting off-target activity of some drug metabolites, using the metabolism of valsartan to 4-hydroxyvaleryl-valsartan as...
View Article
Scientists in the AgChem industry often need to access metabolites of pesticides and herbicides to meet regulatory requirements. For more...
View Article
We will be participating in the 21st North American ISSX meeting taking place in Providence, Rhode Island from September 24th...
View Article
This issue of Hypha’s newsletter focusses on accessing the major circulating and excretory metabolites of the drug lorcaserin. In particular...
View Article
A cell-free kit of cytochrome P450 enzymes and ferredoxin /ferredoxin reductase partners, termed PolyCYPsTM, is being developed for generating scalable...
View Article
